News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
A number of stocks fell in the afternoon session after a report that South Korea's SK Hynix is slowing its high-bandwidth memory (HBM) expansion rattled the AI-chip complex.
8.39am: Telecom Plunge Telecom Plus shares have plummeted 30.5% on the news that management plan to invest in growth, which will hit profits this year. Analyst Charles Hall at house broker Peel Hunt says it is an "aggressive reset" by management, investing £55 million per year to double...
Great things are happening to the stocks in this article. They’re all outperforming the market over the last month because of positive catalysts such as a new product line, constructive news flow, or even a loyal Reddit fanbase.
Cathie Wood’s aggressive buying signals strong confidence in SpaceX, but investors must decide whether Elon Musk’s ambitious AI vision can ultimately justify the company’s lofty valuation.
Earlier in June 2026, Tokyo Electron and Teradyne announced a commercially available integrated test cell that combines Teradyne’s UltraFLEXplus platform with Tokyo Electron’s Prexa SDP prober to deliver known good device screening for chiplet-based AI and data center packages across multiple points in the advanced packaging flow. This collaboration directly targets the reliability challenges of 2.5D and 3D chiplet architectures, potentially making Teradyne’s test systems more relevant to...
The Global X Robotics & Artificial Intelligence ETF (NASDAQ:BOTZ) is the largest pure-play robotics fund in the U.S. market, holding roughly $3.54 billion in net assets across foreign-listed automation giants, U.S. AI chipmakers, and surgical robotics specialists that most retail investors would struggle to buy directly. That access is the real product. It is also ... The Global X Robotics & AI ETF (BOTZ): A Solid Way to Play Robotics
Teradyne (TER) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Teradyne stock tops a proper buy point and is nearing a new high. The chip equipment maker is part of a high-ranking IBD industry group.
A number of stocks jumped in the afternoon session after President Trump announced Apple had agreed to design and manufacture chips with Intel in the United States, a foundry validation the market had been waiting on for over a year.
Teradyne offers more AI-driven upside than AMAT, backed by stronger AI exposure, faster earnings growth and expanding test and packaging opportunities.
Investors in the stock market have several robust growth screens to choose from at Investors.com. Here's where to find them.
Nebius has been high on investors’ radars amid a series of expansion news, contract wins and a surging stock price.
Teradyne, Inc. (NASDAQ:TER) is one of the 10 Best Debt-Free American Stocks to Invest In. On June 11, 2026, Teradyne, Inc. (NASDAQ:TER) said Teradyne Robotics will demonstrate how physical AI is transforming industrial automation at Automate 2026 in Chicago from June 22-25. Jean-Pierre Hathout, President of the Teradyne Robotics Group, said the company’s demos are […]
Zscaler, Inc. (NASDAQ:ZS) was among Jim Cramer’s stock calls on Mad Money, as he highlighted worthy space players and reviewed several of this year’s IPOs. Cramer noted the company’s exit from the Nasdaq-100, as he commented: Then we have some real fireworks coming Thursday night. Thursday’s the last trading day before the Nasdaq rebalances, the […]
Teradyne (NasdaqGS:TER) is set to join the Nasdaq-100 index on June 22, increasing its visibility with large index and ETF investors. The company has secured a multi-year US$139.9 million contract with the U.S. Air Force for diagnostic test station kits. The Air Force agreement expands Teradyne's exposure to government and defense spending beyond its core semiconductor test and robotics operations. Teradyne operates at the intersection of semiconductor test equipment, industrial automation...
At $388.92, Lam Research (LRCX) is being priced to deliver 26.0% revenue growth annually for the next 5 years simply to defend today's 72.5x multiple. That is essentially the 26.5% the business is already running, held steady through 5 more years. Sounds easy until it stops.
In the closing of the recent trading day, Teradyne (TER) stood at $409.35, denoting a -5.33% move from the preceding trading day.
Teradyne will be joining the Nasdaq 100 ahead of market open on June 22.
The company is set to beat consensus estimates for its second-quarter backlog, Cantor Fitzgerald analyst Brett Knoblauch says.
At $388.92, Lam Research (LRCX) looks set up for roughly 51% of upside over the next three years under a conservative scenario. That is a move large enough to justify digging into where it comes from. Revenue compounding does the work, but the multiple takes a meaningful cut along the way. Here is the operational reality the math is built on.
